Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Breakthroughs for Patients, CMC Regulatory Flexibility

This article was originally published in The Gold Sheet

Executive Summary

By compressing clinical timelines, a FDASIA-mandated “breakthrough therapy” application process is pressuring FDA and industry to complete CMC reviews much more quickly. While FDA is emphasizing starting earlier and working harder, industry is talking more about the possibility of deferring some CMC activities post-submission or post-approval.

Advertisement

Related Content

Genentech's Ocrevus Manufacturing Process Still A Work In Progress
Top Stories of 2014
FDA Urges Early Communication of CMC Data Gaps for Breakthrough Therapies
Zykadia Expedited Timeline Challenged By Late-Breaking GMP Concern
Zykadia Expedited Timeline Challenged By Late-Breaking GMP Concern
Zykadia Expedited Timeline Challenged By Late-Breaking GMP Concern
“Breakthrough” Review: FDA And Sponsors Discuss Ways To Improve Efficiency
A “Breakthrough” Reality Check: Sponsors Seek FDA Flexibility On Manufacturing, Diagnostics
“Breakthrough Therapy” Development Speed May Be Tempered By Manufacturing Hurdles

Topics

Advertisement
UsernamePublicRestriction

Register

PS000789

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel